Blondet R, Zlatoff P, Frieh J P, Brunat-Mentigny M, Pasini E, Bobin J Y, Mayer M
J Surg Oncol. 1981;18(2):105-18. doi: 10.1002/jso.2930180202.
The authors study the results of the combined surgery and postoperative chemotherapy, for treatment of pulmonary metastases. At Léon-Bérard Center, 50 patients have been operated on since 1963. The sites and histologies of the primitive cancers are varied, corresponding to 12 epidermoid cancers, 12 adenocarcinomas, 10 osteogenic sarcomas, 1 Ewing's tumor, 3 malignant melanomas, 6 testicular tumors, and 4 others. The total survival rate is 30% in 4 years. The prognosis is influenced by different factors, which are studied. It depends on the histology of the primitive cancer and the type of the pulmonary excision. It is suggested that postoperative chemotherapy improves the results. It appears that the longer the free interval is between the treatment of the primitive cancer and the discovery of the pulmonary metastasis, the better the prognosis. The correlation between the time lapse of the free interval and the survey after pulmonary excision is studied. The conclusions of the authors are: The association of surgery and chemotherapy improves the results and enforces the indications for surgical excision of pulmonary metastases.
作者研究了联合手术及术后化疗治疗肺转移瘤的结果。自1963年以来,里昂-贝拉尔中心对50例患者实施了手术。原发癌的部位和组织学类型各不相同,包括12例表皮样癌、12例腺癌、10例骨肉瘤、1例尤因肉瘤、3例恶性黑色素瘤、6例睾丸肿瘤以及4例其他类型肿瘤。4年总生存率为30%。研究了影响预后的不同因素。预后取决于原发癌的组织学类型及肺切除的方式。建议术后化疗可改善治疗结果。似乎原发癌治疗与肺转移瘤发现之间的无瘤间期越长,预后越好。研究了无瘤间期时长与肺切除术后随访之间的相关性。作者的结论是:手术与化疗联合可改善治疗结果,并强化了肺转移瘤手术切除的指征。